The global Companion
Animal Postoperative Pain Management Therapeutics Market size is expected to reach USD 382.36
million by 2026, registering a CAGR of 6.7% over the forecast period, based on
a new report by Grand View Research, Inc. Increasing number of surgeries in
companion animals is driving the demand for postoperative pain management
drugs.
Increasing companion healthcare
expenditure and concerns among pet owners is further propelling the market
growth. According to The American Pet Products Association report 2018, the
overall spending in U.S. pet industry has increased by 4.1 % from 2016 to 2017.
Moreover, veterinary care spending has increased by 7% from USD 15.95 billion
in 2016 to USD 17.07 billion in 2017.
Significant rise in animal
insurance policies helps pet owners take proper care of their pets. For
instance, in 2017, around 57,000 pet insurance claims were reported for chronic
diseases such as arthritis in pets in U.S. According to a report by the
Department of Clinical Veterinary Science and the Pet Food Institute, around
23% companion animals in U.K. and 30% in Sweden were covered under insurance by
2017.
Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/companion-animal-postoperative-pain-management-therapeutics-market
https://www.grandviewresearch.com/industry-analysis/companion-animal-postoperative-pain-management-therapeutics-market
Further key
findings from the report suggest:
- NSAIDs product segment held the largest revenue share of
the companion animal postoperative pain management therapeutics market, in
year 2018 owing to product availability and affordable pricing
- Canine was the fastest-growing category of companion
animal postoperative pain management therapeutics market in 2018 and is
expected to register a CAGR of 6.9% by 2026 followed by feline segment.
The growth can be attributed to the increase in the number of surgeries in
dogs coupled with new product launch for postoperative pain management
- North America held the largest market share in 2018
owing to the factors, such as presence of major industry players and
increased number of veterinary hospitals in the region
- Asia Pacific is expected to showcase the fastest CAGR
over the forecasted period, attributed to an increase in disposable income
and rising companion ownership in Japan and China
- Zoetis Inc.; Bayer AG; Ceva Polchem; and Norbrook are
some of the major market players
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment